ANGO Historical PE Ratio Notes

— AngioDynamics (ticker symbol: ANGO) is a medical device company specializing in minimally invasive, image-guided therapies for the treatment of peripheral vascular disease, vascular access, and oncology & surgery markets. Their product portfolio includes devices such as angiographic catheters, thrombectomy systems, and ablation technologies, which are used in hospitals and clinics globally to improve patient outcomes. When analyzing ANGO’s historical price-to-earnings (PE) ratio, it is important to recognize that the company’s earnings can be influenced by several factors unique to the medical device industry—including regulatory changes, reimbursement rates, product innovation cycles, and competition from larger healthcare firms. Periods of significant R&D investment or regulatory headwinds may result in reduced or negative earnings, temporarily elevating the PE ratio or making it less meaningful. Conversely, successful product launches or expanding adoption of key technologies can boost earnings and drive the ratio lower, reflecting investor optimism. Therefore, when reviewing historical PE ratio data for AngioDynamics, it is crucial to consider the underlying business drivers and industry-specific events that may have caused short- or long-term swings in profitability, rather than viewing PE trends in isolation.

On this page we presented the ANGO Historical PE Ratio information for AngioDynamics' stock. The average ANGO historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 74.2. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ANGO historical PE based on this TTM earnings result method is 43.3. Note: any PE calculations resulting in a value exceeding 500 were discarded as not meaningful. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ANGO historical PE result, against the recent PE: when this page was posted on 4/24/2026, the most recent closing price for ANGO had been 11.10, and the most recent quarterly earnings result, annualized, was 0.08. Meanwhile, the most recent TTM earnings summed to 0.01. From these numbers, we calculate the recent ANGO PE on 4/24/2026 based on annualized quarterly EPS was 138.8. Based on ANGO's history, that recent PE is elevated relative to the historical average, with the recent PE 87.1% higher than the historical average PE across our data set for AngioDynamics. Looking at the recent ANGO PE on 4/24/2026 based on TTM EPS, we calculate the ratio at 1110.0. Based on ANGO's history, that recent PE is elevated relative to the historical average, with the recent PE 2463.5% higher than the historical average PE across our AngioDynamics data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on ANGO or any other given stock, valuation analysis for ANGO can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate AngioDynamics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ANGO. Thanks for visiting, and the next time you need to research ANGO Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.